Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 14:13:1032789.
doi: 10.3389/fphar.2022.1032789. eCollection 2022.

Clinical study of ganshuang granule combined with tenofovir in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease

Changtian Su  1 , Qin Yang  1
Affiliations

Clinical study of ganshuang granule combined with tenofovir in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease

Changtian Su et al. Front Pharmacol. .

Abstract

Objective: This study aims to investigate the clinical efficacy of Ganshuang granules combined with tenofovir, an antiviral drug, in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease. Methods: A total of 92 patients with chronic hepatitis B combined with non-alcoholic fatty liver who were treated in our Hospital from January 2020 to December 2021 were included as the research objects. According to the method of random number table, the patients were divided into the control group (n = 42) and the treatment group (n = 50). The control group was treated with silibinin meglumine tablets and tenofovir, while the treatment group was treated with Ganshuang granules combined with silybin meglumine tablets and tenofovir. Before and after treatment, liver function index, liver hardness measurement (LSM), controlled attenuation parameter (CAP), HBV-DNA serum load and body mass index (BMI) were observed. Results: Compared with the baseline, ALT, AST and GGT were significantly improved in both groups after treatment (p < 0.05), while TBIL indexes were not significantly different before and after treatment (p > 0.05). Patients in the treatment group had significantly lower ALT and AST index values than the control group at 12 and 24 weeks of treatment (p < 0.05). At 12 and 24 weeks of treatment, the fat attenuation parameters of the two groups were significantly decreased compared with those before treatment, and the difference was statistically significant (p < 0.05). The fat attenuation parameters in the treatment group were significantly lower than those in the control group at 12 and 24 weeks after treatment (p < 0.05). Conclusion: The effect of Ganshuang granule combined with antiviral drugs in the treatment of chronic hepatitis B complicated with non-alcoholic fatty liver is significantly better than that of antiviral drugs alone, which is worthy of clinical recommendation. Systematic Review Registration: https://register.clinicaltrials.gov, identifier NCT05523648.

Keywords: antiviral therapy; chronic hepatitis B; clinical trial; ganshuang granule; non-alcoholic fatty liver disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

References

    1. Cai S., Ou Z., Liu D., Liu L., Liu Y., Wu X., et al. (2018). Risk factors associated with liver steatosis and fibrosis in chronic Hepatitis B patient with component of metabolic syndrome. United Eur. Gastroenterol. J. 6, 558–566. 10.1177/2050640617751252 - DOI - PMC - PubMed
    1. Chan A. W., Wong G. L., Chan H. Y., Tong J. H., Yu Y. H., Choi P. C., et al. (2017). Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic Hepatitis B. J. Gastroenterol. Hepatol. 32, 667–676. 10.1111/jgh.13536 - DOI - PubMed
    1. Chang G. R., Lin W. L., Lin T. C., Liao H. J., Lu Y. W. (2021). The ameliorative effects of saikosaponin in thioacetamide-induced liver injury and non-alcoholic fatty liver disease in mice. Int. J. Mol. Sci. 22, 11383. 10.3390/ijms222111383 - DOI - PMC - PubMed
    1. Chen C. J., Yang H. I., Su J., Jen C. L., You S. L., Lu S. N., et al. (2006). Risk of hepatocellular carcinoma across a biological gradient of serum Hepatitis B virus DNA level. Jama 295, 65–73. 10.1001/jama.295.1.65 - DOI - PubMed
    1. Cheng Y. L., Wang Y. J., Kao W. Y., Chen P. H., Huo T. I., Huang Y. H., et al. (2013). Inverse association between Hepatitis B virus infection and fatty liver disease: A large-scale study in populations seeking for check-up. PloS one 8, e72049. 10.1371/journal.pone.0072049 - DOI - PMC - PubMed

Associated data